Company / Book Value per Share
Sana Biotechnology, Inc. Book Value per Share History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$1.085
FY2024
5-year range
-$32.364 / $4.377
FY2020-FY2024
Trend
-26.6%
vs FY2023
Sector context
#165 of 209
Health Care
What the data says
Sana Biotechnology, Inc.'s book value per share of $1.085 is lower than 79% of companies in the Health Care sector (FY2024). Book Value per Share has declined for 3 consecutive years, from $4.377 in FY2021 to $1.085 in FY2024.
Based on SEC 10-K filings.
$1.085 in FY2024 with a 3-year CAGR of -37.2%.
Declined from $2.651 to $1.085 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -37.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 209This company $1.085 Sector average $189.406
▼
-99.4% below sector average
Key checks
Key Insights
- Sana Biotechnology, Inc.'s book value per share has declined for 3 consecutive years.
- 3-year CAGR of -37.2%, indicating a declining trend.
- In FY2024, book value per share decreased 26.6% year-over-year.
- Ranks #165 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.085 | -26.6% |
| FY2023 | $1.478 | -44.3% |
| FY2022 | $2.651 | -39.4% |
| FY2021 | $4.377 | +113.5% |
| FY2020 | -$32.364 | -11.3% |
| FY2019 | -$29.072 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026